Gene · 4538
Papers2,585
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,585
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia. | Int J Cancer | 2023 | 36533670 | PubTator, text mining | PubMed |
| Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania. | Mol Psychiatry | 2023 | 36513812 | PubTator, text mining | PubMed |
| Genetic testing for mitochondrial disease: the United Kingdom best practice guidelines. | Eur J Hum Genet | 2023 | 36513735 | PubTator, text mining | PubMed |
| Safety of Lenadogene Nolparvovec Gene Therapy Over 5 Years in 189 Patients With Leber Hereditary Optic Neuropathy. | Am J Ophthalmol | 2023 | 36496192 | PubTator, text mining | PubMed |
| Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson's disease. | Brain | 2023 | 36478228 | PubTator, text mining | PubMed |
| Substrate stiffness enhances human regulatory T cell induction and metabolism. | Biomaterials | 2023 | 36455488 | PubTator, text mining | PubMed |
| Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G>A MT-ND4 Mutation. | Ophthalmol Ther | 2023 | 36449262 | PubTator, text mining | PubMed |
| Treatment of Autism Spectrum Disorders by Mitochondrial-targeted Drug: Future of Neurological Diseases Therapeutics. | Curr Neuropharmacol | 2023 | 36411568 | PubTator, text mining | PubMed |
| NNMT-DNMT1 Axis is Essential for Maintaining Cancer Cell Sensitivity to Oxidative Phosphorylation Inhibition. | Adv Sci (Weinh) | 2023 | 36382559 | PubTator, text mining | PubMed |
| Signatures of positive selection in the mitochondrial genome of neotropical freshwater stingrays provide clues about the transition from saltwater to freshwater environment. | Mol Genet Genomics | 2023 | 36378333 | PubTator, text mining | PubMed |
| Role of SIRT3 in neurological diseases and rehabilitation training. | Metab Brain Dis | 2023 | 36374406 | PubTator, text mining | PubMed |
| Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy. | Brain | 2023 | 36350566 | PubTator, text mining | PubMed |
| Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution. | Nat Biotechnol | 2023 | 36302989 | PubTator, text mining | PubMed |
| Developmental toxicity of prometryn induces mitochondrial dysfunction, oxidative stress, and failure of organogenesis in zebrafish (Danio rerio). | J Hazard Mater | 2023 | 36272374 | PubTator, text mining | PubMed |
| Precision mitochondrial DNA editing with high-fidelity DddA-derived base editors. | Nat Biotechnol | 2023 | 36229610 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Single-cell RNAseq provides insight into altered immune cell populations in human fracture nonunions. | J Orthop Res | 2023 | 36200412 | PubTator, text mining | PubMed |
| Kearns-Sayre syndrome case. Novel 5,9 kb mtDNA deletion. | Mol Genet Genomic Med | 2023 | 36181358 | PubTator, text mining | PubMed |
| High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD). | J Cancer Res Clin Oncol | 2023 | 36173462 | PubTator, text mining | PubMed |
| Mitochondrial DNA variation in Alzheimer's disease reveals a unique microprotein called SHMOOSE. | Mol Psychiatry | 2023 | 36127429 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4538/papers?page=20